Lymphatic Diseases

• CLINICAL_TRIALS trial_result · 2026-06-09
  Clinical Trial Results: PRIMO Post-Market Clinical Follow Up Study [NA]

  Post-market clinical follow-up study results for the PRIMO device from MMI, completed with results posted.

• CLINICAL_TRIALS research · 2025-12-08
  Clinical Trial Update: Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma [Phase 1]

  Phase 1 clinical trial update of anti-CD19 CAR-T cells with an inducible caspase-9 safety switch for B-cell lymphoma, currently active but n…

• CLINICAL_TRIALS withdrawal · 2023-04-21
  Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]

  A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2022-11-17
  Clinical Trial Update: Sildenafil for the Treatment of Lymphatic Malformations [Phase 2]

  Phase 2 clinical trial update evaluating sildenafil for treating lymphatic malformations; results posted after completion.

• CLINICAL_TRIALS trial_result · 2022-03-22
  Clinical Trial Update: Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients [Phase 2]

  Phase 2 trial investigating brentuximab vedotin as a single agent for relapsed/refractory CD30+ peripheral T-cell lymphoma (PTCL).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2019-09-23
  Clinical Trial Update: Effectiveness of Intracavitary Manual Lymphatic Drainage [Phase 4]

  Phase 4 clinical trial update evaluating the effectiveness of intracavitary manual lymphatic drainage for lymphatic diseases has completed.